Bank of America
SIOX

Bank of America’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bank of America’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60,863
Closed -$3.35M – 7339
2017
Q3 		$3.35M Buy
+60,863
New +$10.3M ﹤0.01% 3547

Other funds holding SIOX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Bank of America's SIOX Position: Q1 2023 in Review

Bank of America sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 244 shares — an estimated $106 sold.

Bank of America first reported a position in SIOX in Q2 2015 and held it in 31 quarters. The position peaked at $2.45M in Q3 2017. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

  • Bank of America reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 244 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $106.
  • Bank of America first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 31 quarters.
  • Bank of America's Sio Gene Therapies Inc. Common Stock position peaked at $2.45M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.